David M Lang

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. doi request reprint An overview of EPR3 asthma guidelines: what's different?
    David M Lang
    Department of Pulmonary, Allergy, and Critical Care, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Allergy Asthma Proc 28:620-7. 2007
  2. ncbi request reprint The long-acting beta-agonist controversy: a clinical dilemma
    David M Lang
    Allergy Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Allergy Asthma Proc 28:136-44. 2007
  3. ncbi request reprint The controversy over long-acting beta agonists: examining the evidence
    David M Lang
    Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 73:973-6, 978, 981-4 passim. 2006
  4. ncbi request reprint Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?
    David M Lang
    Cleveland Clinic, 9500 Euclid Avenue, Desk C22, Cleveland, OH 44195, USA
    Curr Allergy Asthma Rep 8:37-44. 2008
  5. ncbi request reprint New asthma guidelines emphasize control, regular monitoring
    David M Lang
    Respiratory Institute, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 75:641-53. 2008
  6. ncbi request reprint Asthma deaths and the athlete
    David M Lang
    Allergy and Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA
    Clin Rev Allergy Immunol 29:125-9. 2005
  7. doi request reprint Hospitalizations for asthma in an urban population: 1995-1999
    David M Lang
    Respiratory Institute, Section of Allergy and Immunology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Ann Allergy Asthma Immunol 103:128-33. 2009
  8. doi request reprint Glatiramer acetate: successful desensitization for treatment of multiple sclerosis
    Sonia N Bains
    Department of Allergy and Immunology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Ann Allergy Asthma Immunol 104:321-5. 2010
  9. doi request reprint The role of allergy evaluation in adults with eosinophilic esophagitis
    Joshua D Penfield
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Clin Gastroenterol 44:22-7. 2010
  10. doi request reprint Asthma in African Americans: what can we do about the higher rates of disease?
    Stacy K Silvers
    Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 79:193-201. 2012

Collaborators

Detail Information

Publications21

  1. doi request reprint An overview of EPR3 asthma guidelines: what's different?
    David M Lang
    Department of Pulmonary, Allergy, and Critical Care, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Allergy Asthma Proc 28:620-7. 2007
    ..The revisions in asthma management proposed in these guidelines offer the potential for improved normative care outcomes in asthmatic patients in the United States...
  2. ncbi request reprint The long-acting beta-agonist controversy: a clinical dilemma
    David M Lang
    Allergy Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Allergy Asthma Proc 28:136-44. 2007
    ..After the PBL case discussion, a didactic lecture was presented describing the evidence pertaining to the LABA controversy, which is detailed in this article...
  3. ncbi request reprint The controversy over long-acting beta agonists: examining the evidence
    David M Lang
    Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 73:973-6, 978, 981-4 passim. 2006
    ..As a result, medications that contain salmeterol (Serevent, Advair) or formoterol (Foradil) carry a "black box warning." However, the benefits of these drugs continue to outweigh the risks, if they are used appropriately...
  4. ncbi request reprint Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?
    David M Lang
    Cleveland Clinic, 9500 Euclid Avenue, Desk C22, Cleveland, OH 44195, USA
    Curr Allergy Asthma Rep 8:37-44. 2008
    ....
  5. ncbi request reprint New asthma guidelines emphasize control, regular monitoring
    David M Lang
    Respiratory Institute, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 75:641-53. 2008
    ..The revisions in asthma management proposed in these guidelines offer the potential for improved asthma care outcomes in the United States...
  6. ncbi request reprint Asthma deaths and the athlete
    David M Lang
    Allergy and Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA
    Clin Rev Allergy Immunol 29:125-9. 2005
    ..Rather, this should reinforce the message that asthma is a condition that may be potentially serious, but can, and should be, well controlled with proper management...
  7. doi request reprint Hospitalizations for asthma in an urban population: 1995-1999
    David M Lang
    Respiratory Institute, Section of Allergy and Immunology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Ann Allergy Asthma Immunol 103:128-33. 2009
    ..Medications and demographic factors affect asthma hospitalization rates. Recent studies suggest that inhaled long-acting beta-agonists (LABAs) may heighten risk of serious asthma exacerbation, particularly in African Americans...
  8. doi request reprint Glatiramer acetate: successful desensitization for treatment of multiple sclerosis
    Sonia N Bains
    Department of Allergy and Immunology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Ann Allergy Asthma Immunol 104:321-5. 2010
    ..It is also associated with immediate postinjection systemic reactions in approximately 10% of patients. To our knowledge, no desensitization protocols for glatiramer acetate have been published to date...
  9. doi request reprint The role of allergy evaluation in adults with eosinophilic esophagitis
    Joshua D Penfield
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Clin Gastroenterol 44:22-7. 2010
    ..Allergy evaluation and skin prick testing for foods are recommended in all patients with eosinophilic esophagitis. However, the yield of allergy evaluation in adult eosinophilic esophagitis is not known...
  10. doi request reprint Asthma in African Americans: what can we do about the higher rates of disease?
    Stacy K Silvers
    Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 79:193-201. 2012
    ..Further work is needed to better understand these complex risk factors. To remedy these disparities, we need to ensure that patients at higher risk are given proper care and the knowledge to control their asthma...
  11. doi request reprint Utility of routine laboratory testing in management of chronic urticaria/angioedema
    James A Tarbox
    Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Ann Allergy Asthma Immunol 107:239-43. 2011
    ..Laboratory tests are routinely ordered to identify or rule out a cause in patients with chronic urticaria/angioedema (CUA). The results of these tests are usually within normal limits or unremarkable...
  12. ncbi request reprint Management of group B Streptococcus in pregnant women with penicillin allergy
    Elliot H Philipson
    Department of Obstetrics and Gynecology, Hillcrest Hospital, Cleveland Clinic Foundation, 6770 Mayfield Road, Suite 336, Mayfield Heights, OH 44124, USA
    J Reprod Med 52:480-4. 2007
    ....
  13. doi request reprint Food allergy is associated with potentially fatal childhood asthma
    Nicola M Vogel
    The Children s Hospital, The Cleveland Clinic Foundation, Center for Pediatric Allergy and Immunology, Cleveland, Ohio 44195, USA
    J Asthma 45:862-6. 2008
    ..Risk factors for potentially fatal childhood asthma are incompletely understood...
  14. ncbi request reprint Omalizumab: where does it fit into current asthma management?
    Todd E Rambasek
    Section of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 71:251-61. 2004
    ..This review discusses how this drug works, which patients will be candidates for it, and the practical aspects of using it...
  15. ncbi request reprint Allergy diagnostic testing: an updated practice parameter
    I Leonard Bernstein
    University of Cincinnati College of Medicine, Ohio, USA
    Ann Allergy Asthma Immunol 100:S1-148. 2008
  16. ncbi request reprint Blocking aspirin-induced bronchospasm
    David M Lang
    Ann Allergy Asthma Immunol 95:307-8. 2005
  17. doi request reprint The diagnosis and management of rhinitis: an updated practice parameter
    Dana V Wallace
    J Allergy Clin Immunol 122:S1-84. 2008
  18. ncbi request reprint Feasibility of a national fatal asthma registry: more evidence of IRB variation in evaluation of a standard protocol
    Sunday Clark
    Massachusetts General Hospital, Boston, MA, USA
    J Asthma 43:19-23. 2006
    ..The project was revived in 2004 when a standard protocol was submitted to Institutional Review Boards (IRBs) in four different states...
  19. ncbi request reprint Stinging insect hypersensitivity: a practice parameter update
    John E Moffitt
    Joint Council of Allergy, Asthma and Immunology, 50 N Brockway St, 3 3, Palatine, IL 60067, USA
    J Allergy Clin Immunol 114:869-86. 2004
  20. ncbi request reprint Physical activity in urban school-aged children with asthma
    David M Lang
    Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
    Pediatrics 113:e341-6. 2004
    ..To compare the physical activity levels of children with and without asthma and evaluate predictors of activity level in children with asthma...
  21. ncbi request reprint Evidence-based protocols for oral NSAID challenges
    Donald D Stevenson
    J Pediatr 148:704-5; author reply 705-6. 2006